An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for ILLUMINA Inc
| Ticker | ILMN |
| FIGI | BBG000DSMS70 |
| CUSIP | 452327109 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 723 / 10.3% |
| Percentage held by institutional investors | 100.0% |
About
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California, and it serves more than 155 countries. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Wikipedia